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Abstract
Background: Rare diseases (RD) are those that present a lower prevalence than 5 cases per 10.000 population. The 
main objective of this review was to study the effect on oral health in rare diseases, while the secondary objective 
of the study is theme upgrade. 
Material and Methods: Comparative observational case-control studies were analysed and a systematic review was 
conducted in PubMed. Each rare disease listed on the statistical data record of the Health Portal of the Ministry of 
Equality, Health and Social Policies Board of Andalusia was associated with “oral health”. The variables studied 
included dental, oral mucosa and occlusion alterations, oral pathologies (caries, periodontal disease) and other 
alterations (mouth breathing, parafunctional habits, etc). A bias analysis of the variable caries was conducted. 
Results: Six RD were selected through our inclusion and exclusion criteria (hypogammaglobulinemia, Rett syn-
drome, Marfan syndrome, Prader-Willi syndrome, cystic fibrosis and Cri du chat syndrome) in a total of 8 publi-
cations, of which four trials were classified as high risk of bias and one of them as medium risk.  There were not 
trials with low risk of bias. 
Conclusions: The main statistically significant differences found by Syndrome compared to a control group were 
in Hypogammaglobulinemia with a greater tendency to enamel hypoplasia and dry mouth. The Rett syndrome 
had, as well, a greater tendency to an anterior open bite, ogival palate, bruxism, mouth breathing and tongue 
thrusting. Prader-Willi syndrome had a tendency of dental erosion, and Cri du chat syndrome showed a higher 
association to Tannerella forsythia. 
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Introduction
The European Commission defines rare diseases (RD) 
as all diseases with a prevalence lower than 5 cases per 
10.000 population (1). In Spain, the Epidemiology of 
Rare Disease Research Network (REpIER), describes 
a set of characteristics, of which, at least one of them 
has to be present in the disease to be recognized as rare: 
chronicity, lack of knowledge of the etiology of the dis-
ease, lack of treatment or poor accessibility, a signifi-
cant disease burden or limitations on quality of life.
In recent years, the classification of diseases has 
undergone continuous modifications determined by 
new genetic findings that subdivide diseases, which 
were previously under the same category (2). Rare 
diseases can occur at any age and they present a wide 
range of alterations and symptoms that vary not only 
from one disease to another, but from patient to patient 
according to the degree of affectation and evolution. 
Manifestations, alterations and oral pathologies can be 
found within this diversity. 
The principal objective of this review was to study the 
affectation of oral health in RD, based on statistical data 
recorded in the Autonomous Community of Andalusia. 
The secondary objective is a theme upgrade.
Material and Methods
The present systematic review focuses on case-control 
observational comparative studies in humans with 
rare diseases associated with oral health. Theses RD 
are registered in the section “statistical data on rare 
diseases” of the Health Portal of the Department of 
Equality, Health and Social Policies of the Regional 
Government of Andalusia. The cases documented in 
Andalusia on this list are 76 RD. Since this review 
does not involve humans, it does not require the Ethics 
Committee approval. 
- Inclusion and exclusion criteria
The inclusion criteria were case-control trials published 
in English in the last 10 years to date (2004-2014). The 
exclusion criteria were the articles that did not meet the 
inclusion criteria and from the list above mentioned the 
Down syndrome was ruled out since it is not considered 
a rare disease because of the information collected 
during 1980-2007 by the Spanish Collaborative Study 
of Congenital Deformities, it shows that approximately 
11 children out of 10.000 born had Down Syndrome.  
- Search strategy and data collection
The search strategy was developed using a flow chart 
described on the article wrote by Urrutia et al. (3) about 
PRISMA declaration.  We started the research on July 
15th 2014 using PubMed database; we typed the name 
of each RD from the list of the documented cases in 
Andalusia, except for Down syndrome (75), “AND” 
“oral health” in the search field. The last search was 
carried out on December 30th 2014.
As an initial selection, we read the title and the abstract 
of each article, except for those that were not associated 
to oral health. The inclusion criteria were applied to 
these articles, and the ones that met the eligibility criteria 
were analyzed using the next variables: country of 
origin, sample size and sample average age on the study 
group (SG) and control group (CG). On each article the 
next characteristics of the patients were reviewed and 
analyzed: 1. Dental alterations (type of alteration within 
form, color, position, number and structure). 2. Soft tissue 
alterations (Tongue: alterations of form and size; Lips: 
pathologies that affect lips; Soft tissues: pathologies that 
affect mucous). 3. Abnormalities on dental occlusion: 
type of malocclusion. 4. Oral pathology (Caries: if 
patients with a RD are more or less prone to caries than 
patients in the control group; Gingivitis: if patients with 
a RD are more or less prone to gingivitis than patients in 
the control group; Periodontal disease: if patients with 
a RD are more or less prone to periodontal disease than 
patients in the control group). 5. Others (Parafunctional 
habits: thumb sucking, lip sucking, tongue thrusting, 
bruxism, onychophagia, mouth breathing and any oral 
characteristics that cannot be included in the above 
sections).
- Bias analysis
Bias analysis was performed with caries variable, since 
it has been the most studied in the selected articles. The 
risk of bias was evaluated in different levels: clinical 
trial (selection of the control group and statistical analy-
sis), and results (the validity of the measure, the number 
of examiners, and accuracy) using the seven criteria 
listed below and that were adapted from the PRISMA 
declaration (4): 1) a control group included; 2) a control 
group justified; 3) statistical approach justified; 4) vali-
dated the measurement used for dental caries (i.e. De-
cayed, Missing or Filled Surfaces in deciduous dentition 
[dmfs],Decayed, Missing or Filled Tooth in deciduous 
dentition [dmft], Decayed, Missing or Filled Surfaces 
in permanent dentition [DMFS], Decayed, Missing or 
Filled Tooth  in permanent dentition [DMFT]); 5) dif-
ferent highly trained dental examiners; 6) blind dental 
examiners; 7) assessed the intra and/or inter reliability 
of the evaluator. The trials that fulfilled the seven cri-
teria were classified as low risk of bias.  The trials that 
fulfilled four or six criteria were classified as medium 
risk of bias, and the remaining trials were classified as 
high risk of bias.
- Statistical analysis
The Kappa index of agreement between the two authors 
(AM and PM) was calculated. Significant statistical val-
ues  found according to the variables analyzed in each 
study are shown in table 1 marked with an asterisk.
Results and Discussion
The main objective of this systematic review was to 
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assess the effect on oral health in rare diseases (RD) 
we have registered with statistical data in the System 
Health of the Government of Andalusia.
The search performed by the authors (AM and PM) 
showed 898 publications from the Medline (PubMed) 
data base. Based on information provided in the title 
and the abstract of the study, 31 RD were excluded, with 
a total of 207 publications (Fig. 1). Eight studies met 
Fig. 1. PRISMA® flowchart describing the search strategy and inclusion of the studied articles.
the inclusion criteria (5-12) and were incorporated to the 
systematic review, the bias analysis of the viable caries 
was carried out in a total of 5 publications (5-7,10,11) 
with 4 RD, excluding publications of Cri du Chat syn. 
and Prader-Willi syn. where this variable was not 
studied. 
The wording of the article was conducted by (AM and 
LC) and the investigation led by (GM). The Kappa in-
dex between both authors (AM and PM) was k > 0.79, 
obtaining an acceptable agreement.
The data acquired from each publication are shown 
in table 1 (we only specify data about the study group 
variable and if it increases or reduces in relation to 
the control group). Most of the clinical trials were 
published between 2012 and 2014 (5-8,10,12) and the 
population they include was from European countries 
(6-9,11,12). The sample size varies depending on the 
clinical trial, the one that shows the largest sample size 
is a publication made in Brazil (5) with 100 patients 
in the study group and 93 in the control group.  The 
average age of all publications ranges between 9 and 21 
years old; only two clinical trials (5,7) have an average 
age between 35 and 40 years old.  The variable, oral 
pathology, is the most studied in the majority of the 
clinical trials (5-7,10,11) followed by dental alterations. 
The rare diseases that have the most studied variables 
are Hypogammaglobulinemia and Rett syndrome.  The 
Chi-squared test (5,6,10) was the most used statistical 
treatment along with the Ficher exact test (5,6); there is 
only one clinical trial (11) that did not use any statistical 
analysis.
Analysis based on risk of bias: Four clinical trials were 
classified as high risk of bias and one of them as medium 
risk of bias (Table 2). There were not trials with low risk 
of bias. All the clinical trials had a control group, but 
none of them had a particular reason why this group 
was selected as control group. Three studies specify the 
statistical analysis performed.  All clinical trials adopted 
standard measures of dental caries (i.e. dmt and DMF). 
Most of the clinical trials had only one examiner, and 
only one of them provided enough information about 
the intra or inter reliability of the evaluators. 
Nowadays, one of dental research priorities should be 
to improve the knowledge regarding the relationships 
between rare diseases and oral cavity, finding new treat-
ment modalities, adapting existing ones and looking for 
reasonable patient comfort without overtreating. Col-
laborate with screening programs and treatment of rare 
diseases must be a dentistry goal. The clinical impact 
of this systematic review in daily dental practice indi-
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cates the need to incorporate systematic prevention and 
monitoring of these patients in order to decrease the 
oral pathology associated with rare diseases. In recent 
decades it has seen a greater social interest in the pa-
tients included in this group of rare diseases. One of the 
current metric of social progress, is the increase in the 
quality of provided care. Improving the quality of life 
and social well-being is of vital importance in the com-
munity impact. The bibliometric impact that this article 
can have is relevant as is concerned a social aspect that 
has not previously been discussed in any study. It is the 
first systematic review carried out in relation to oral 
health status in patients with rare diseases.
One of the limitations of our review, was the need for 
synthesis of such a vast subject as are the RD. We have 
excluded RD with characteristics that affect oral health 
that not meet the inclusion criteria, which were case-
control studies over the last ten years up to this date 
(Fig. 1). For this reason, this review suggests that more 
clinical trials should be carried out to evaluate each RD 
individually. 
The secondary objective of the review is to update the 
theme. A brief description of general and oral charac-
teristics that can be found in each of the syndromes in-
cluded in this review are mentioned.
-Hypogammaglobulinemia 
Hypogammaglobulinemia is a group of disorders charac-
terized by low levels of serum immunoglobulins (13). Un-
til January 2013, there were 204 cases recorded in Anda-
lusia with an average age of 62 years, it is high if we com-
pare these numbers with the study carried out in the Bra-
zilian population (5) with a mean value of 35 years of age. 
A justified reason was not found about the large dif-
ference of age, although it is known that the old-age 
population ratio in Spain is larger.  Regarding the oral 
characteristics of this disease, no other study was found 
in the literature in order to discuss the matter.
Hypogammaglobulinemia (5) had dental and soft tis-
sue alterations, oral pathology and “others”. Enamel 
hypoplasia and dry mouth sensation were statistically 
significant, in relation to the control group, followed by 
periodontal disease and caries.
-Rett Syndrome
Rett syndrome is a neurological disorder characterized 
by the regression of the psychomotor development with 
autism, head growth deceleration, seizures and a repeti-
tive stereotyped hand movement (14). Fuertes-González 
et al. (15), carried out a literature review between 1985 
and 2007 about oral health in people with Rett syndrome 
and it was observed that only two studies, out of seven, 
had more than one case with this characteristics; brux-
ism was the most seen variable, which is in line with the 
study performed by Fuertes-González et al. (6) in 2014 
found that of the 41 cases observed among the popula-
tion of Valencia and Murcia, 73.2% had bruxism, being 
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statistically significant. Rett syndrome (6) had dental 
and occlusion alterations, oral pathology and “others”. 
However, anterior open bite, ogival palate, bruxism, 
mouth breathing and lip interposition were statistical-
ly significant. Caries was less significant in the study 
group regarding the control group.
-Marfan syndrome
Marfan syndrome is an autosomal dominant genetic 
disease that affects connective tissue elastics fibers, ap-
pearing in systems or organs, such as the cardiovascu-
lar, skeletal, eye, skin, and lung (16,17). Only one study 
analyzed the variables caries and periodontal disease, 
not been statistical significant compared to the control 
group. (7). However, Morales-Chávez et al.  (18) con-
ducted a small literature review and found studies as the 
one from Bauss et al.  (19) that showed  a greater preva-
lence of pulp obliteration and pulp stones formation. In 
a clinical trial with 21 cases of Marfan syndrome (20) a 
high prevalence of the temporomandibular joint disor-
ders were found, they were caused by subluxations and 
an anterior disk displacement. 
-Prader-Willi syndrome 
Prader-Willi syndrome is a complex disorder charac-
terized by hypotonia, severe feeding problems, hyper-
phagia and obesity during early childhood, low height, 
facial dysmorphic disorder, hypogonadism and learning 
and behavioral problems (21). Prader-Willi syndrome 
had dental and soft tissue alterations (9). Dental erosion 
was also the most seen variable in the study performed 
by Saeves et al. (8) included in our review where 45 
cases with RD had a mean value of dental erosion of 
1.15±1.1 regarding the control group [45] with 0.18±0.3. 
Balleui-Forestier et al. (22) carried out their own study 
with 15 patients with Prader-Willi syndrome and the 
most seen characteristic was dental erosion, not for the 
number of cases that had this alteration, because there 
were only 4 cases, but for the large quantity of dental 
erosion. 
-Cystic fibrosis 
Cystic fibrosis is the most common autosomic recessive 
lethal disease in Caucasian population, it is catheterized 
by abnormal concentrations of electrolyte in exocrine 
secretion and the inability to eliminate mucous 
secretions, which causes obstruction and accumulation 
of bacteria in the digestive and respiratory system as 
well as the reproductive tract. It also causes abnormal 
levels of chloride in sweat (23). Children and teenagers 
with cystic fibrosis have a greater risk of dental caries 
because of four factors related to this disease (24): 
oral Streptococcus Mutans increase 20 times more, 
gastroesophageal reflux, enamel alterations and a high-
calorie diet to maintain weight. 
Despite these risk factors, most of the clinical trials of 
the last 20 years show that people with cystic fibrosis 
have a low risk of dental caries (25,26). Nevertheless, 
in 2013 Chi et al. (27) carried out a systematic review 
about caries prevalence in children and teenagers with 
cystic fibrosis and observed that teenagers that did not 
have this disease had less caries than teenagers with 
cystic fibrosis. This result matches with the studies in 
our review, except for the group between 13 to 24 years 
old with permanent dentition since they had less caries 
than the control group (11).
There is a theory that establishes that antibiotics reduce 
intraoral levels of Streptococcus mutans, which in turn 
reduce risk of caries.  This theory may be true if we 
apply this to children but not in teenagers with cystic 
fibrosis because when the child is 11 years old, there 
is a microbiological change at respiratory level that 
makes Pseudomonas Aeruginosa (gram-negative) the 
predominant bacteria.  New antibiotics were developed 
to solve this problem including inhaled tobramicyn, 
which is an aminoglycoside that fights against P. 
aeruginosa and it is commonly prescribed for teenagers 
with cystic fibrosis (28). Since tobramicyn does not 
affect S. mutans bacteria, teenagers with this disease 
can lose protection against caries.  In fact, taking this 
gram-negative antibiotic inhaled may make an ecologic 
pressure that favors gram-positive bacteria as S. mutans, 
which elevates risk of caries. 
The clinical trials included in this review do not describe 
enamel alterations, however, different studies (25,26) 
agree that patients diagnosed with cystic fibrosis have 
a higher percentage of enamel alterations in permanent 
dentition, from which the most common is hypoplasia. 
Azevedo et al. (29) mentioned that probably the high 
incidence of enamel defects may be a result of a 
nutritional and metabolic imbalance, as well as, long-
term pharmacological treatments, which are often seen 
in patients with chronic cystic fibrosis.   
Regarding dental erosion, it was not statically significant 
in children with cystic fibrosis or the control group with 
healthy patients (10). No other study was found that 
considers dental erosion, however, the esophageal reflux 
and the inhaled medication that patients with cystic 
fibrosis take, may have an influence in the presence of 
dental erosion.
Cystic fibrosis (10,11) had dental alterations, oral 
pathology and others. It did not have any significant 
characteristic regarding the control group. 
-Cri du chat syndrome 
Cri du chat syndrome was diagnosed, for the first time, 
as a chromosomopathy because of the partial or total 
loss of the short arm of 5 chromosome, in 1963 by 
Lejeune et al. (30).  Its clinical characteristics include 
a typical cat-like cry, facial dimorphism, microcephaly, 
and severe retardation in mental and psychomotor 
development. Despite being considered as a rare genetic 
disease, is one of the most common syndromes caused 
by chromosomal deletion in humans (1:15.000-1:50.000). 
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There are 83 recorded cases of Cri du chat syndrome in 
Andalusia up to 2013.
Cri du chat syndrome had only oral pathology and 
was found a statistically significant greater association 
with Tannerella forsythia in the study group (12). This 
case-control study shows that there may be a microbial 
predisposition, which causes periodontitis. Some 
statistically significant differences were observed only 
regarding Tannerella forsythia, because the quantity 
of this bacteria was higher in the group with Cri Du 
Chat syn. than the control group. Therefore, the 
authors conclude that T. forsythia is closely associated 
with patients that present Cri du chat syn., rather than 
patients in the control group.  Besides, other authors 
used the Community Periodontal Index of Treatment 
Needs (CPITN) to demonstrate that a small percentage 
(22.9%) did not show any sign of periodontal disease 
(31).  However, a greater predisposition to periodontal 
disease may be associated with poor oral hygiene 
commonly observed in people with mental disability 
(32).
One study showed that 56.06% of a total of 31 patients 
with Cri du chat syn. brushed their teeth by themselves 
without adult supervision (31). The author of this study 
highlighted the importance of Cri du chat syndrome 
and oral hygiene, since multiple factors did not help to 
clarify the association between both, as for example, the 
diet, the cognitive level of the patient and the way the 
brushing was performed.   
There are more characteristics, which are quite 
common in this syndrome, for example, mandibular 
retrognathism that has a percentage of 90.63% over 32 
cases with Cri du chat syn. (31) or a 70% over 10 cases 
(33), ogival palate has a 55.17% over 29 cases and the 
anterior open bite had a 63.33% over 30 cases (30).
People with this syndrome can also have defects in 
the dental tissue, being the most common enamel 
hypoplasia with 54% over 23 patients (31). Moreover, 
Rodríquez-Caballero et al. (31) observed some dental 
defects with a lower percentage, like dental opacities 
(33%), dental agenesis (9%), macrodontia (6%), 
supernumerary teeth (3%),  root resorption (3%) and 
dental transposition (3%). A comprehensive review 
centered in oral and craniofacial manifestations of this 
syndrome has recently been published by the authors of 
this review (34).
Conclusions
The main statistically significant differences found by 
Syndrome compared to a control group were: in Hypog-
ammaglobulinemia enamel hypoplasia and dry mouth; 
in Rett Syndrome anterior open bite, arched palate, 
bruxism, mouth breathing and lip interposition; in Mar-
fan syndrome no statistically significant differences 
were found; in Prader-Willi Syndrome dental erosion; 
in cystic fibrosis no significant differences were found 
and in Cri Du Chat syndrome increased presence of 
bacteria Tannerella forsythia.
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